Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Something new under the skin

One-size-fits-all intravenous delivery of biologics may be giving way to alternate delivery routes that enable safer and more efficient drug administration. Michael Eisenstein reports.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Cortelezzi, A. et al. Leukemia 23, 2027–2033 (2009).

    CAS  Article  Google Scholar 

  2. Stilgenbauer, S. et al. J. Clin. Oncol. 27, 3994–4001 (2009).

    CAS  Article  Google Scholar 

  3. Li, G. et al. Int. J. Pharm. 368, 109–115 (2009).

    CAS  Article  Google Scholar 

  4. Ottiger, M. et al. Invest. Ophthalmol. Vis. Sci. 50, 779–786 (2009).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Supplementary information

Supplementary Text and Figures

Supplementary Table (XLS 22 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Eisenstein, M. Something new under the skin. Nat Biotechnol 29, 107–109 (2011).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing